346 related articles for article (PubMed ID: 29116623)
21. Clinicopathologic characteristics and outcomes of gastric cancers with the MSI-H phenotype.
Seo HM; Chang YS; Joo SH; Kim YW; Park YK; Hong SW; Lee SH
J Surg Oncol; 2009 Mar; 99(3):143-7. PubMed ID: 19117018
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of fibroblast growth factor receptor 2 expression in patients with residual rectal cancer after preoperative chemoradiotherapy: relationship with KRAS or BRAF mutations and MSI status.
Yoon G; Lee H; Kim JH; Hur K; Seo AN
Tumour Biol; 2016 Aug; 37(8):10209-18. PubMed ID: 26831663
[TBL] [Abstract][Full Text] [Related]
23. Molecular key to understand the gastric cancer biology in elderly patients-The role of microsatellite instability.
Polom K; Marrelli D; Roviello G; Pascale V; Voglino C; Rho H; Marini M; Macchiarelli R; Roviello F
J Surg Oncol; 2017 Mar; 115(3):344-350. PubMed ID: 27859280
[TBL] [Abstract][Full Text] [Related]
24. RAS status in Korean patients with stage III and IV colorectal cancer.
Lee WS; Lee JN; Baek JH; Park YH
Clin Transl Oncol; 2015 Sep; 17(9):751-6. PubMed ID: 25997687
[TBL] [Abstract][Full Text] [Related]
25. Microsatellite Instability Analysis in Gastric Carcinomas of Moroccan Patients.
Nshizirungu JP; Bennis S; Mellouki I; Benajah DA; Lahmidani N; El Bouhaddoutti H; Ibn Majdoub K; Ibrahimi SA; Pires Celeiro S; Viana-Pereira M; Manuel Reis R
Genet Test Mol Biomarkers; 2021 Feb; 25(2):116-123. PubMed ID: 33596142
[No Abstract] [Full Text] [Related]
26. The pattern of lymph node metastases in microsatellite unstable gastric cancer.
Polom K; Marrelli D; Pascale V; Ferrara F; Voglino C; Marini M; Roviello F
Eur J Surg Oncol; 2017 Dec; 43(12):2341-2348. PubMed ID: 28942235
[TBL] [Abstract][Full Text] [Related]
27. Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability.
Umeda Y; Nagasaka T; Mori Y; Sadamori H; Sun DS; Shinoura S; Yoshida R; Satoh D; Nobuoka D; Utsumi M; Yoshida K; Yagi T; Fujiwara T
J Hepatobiliary Pancreat Sci; 2013 Feb; 20(2):223-33. PubMed ID: 23010994
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological and molecular alterations in early gastric cancers with the microsatellite instability-high phenotype.
Sugimoto R; Sugai T; Habano W; Endoh M; Eizuka M; Yamamoto E; Uesugi N; Ishida K; Kawasaki T; Matsumoto T; Suzuki H
Int J Cancer; 2016 Apr; 138(7):1689-97. PubMed ID: 26538087
[TBL] [Abstract][Full Text] [Related]
29. Molecular Profiling Based on KRAS/BRAF Mutation, Methylation, and Microsatellite Statuses in Serrated Lesions.
Sugai T; Eizuka M; Fujita Y; Kawasaki K; Yamamoto E; Ishida K; Yamano H; Suzuki H; Matsumoto T
Dig Dis Sci; 2018 Oct; 63(10):2626-2638. PubMed ID: 29974407
[TBL] [Abstract][Full Text] [Related]
30. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
[TBL] [Abstract][Full Text] [Related]
31. High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases.
Fujiyoshi K; Yamamoto G; Takahashi A; Arai Y; Yamada M; Kakuta M; Yamaguchi K; Akagi Y; Nishimura Y; Sakamoto H; Akagi K
Oncol Rep; 2017 Feb; 37(2):785-792. PubMed ID: 28000889
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-8 gene polymorphism associated with susceptibility to non-cardia gastric carcinoma with microsatellite instability.
Shirai K; Ohmiya N; Taguchi A; Mabuchi N; Yatsuya H; Itoh A; Hirooka Y; Niwa Y; Mori N; Goto H
J Gastroenterol Hepatol; 2006 Jul; 21(7):1129-35. PubMed ID: 16824064
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy.
Haag GM; Czink E; Ahadova A; Schmidt T; Sisic L; Blank S; Heger U; Apostolidis L; Berger AK; Springfeld C; Lasitschka F; Jäger D; von Knebel Doeberitz M; Kloor M
Int J Cancer; 2019 Apr; 144(7):1697-1703. PubMed ID: 30499151
[TBL] [Abstract][Full Text] [Related]
34. Does neoadjuvant therapy alter KRAS and/or MSI results in rectal adenocarcinoma testing?
Ondrejka SL; Schaeffer DF; Jakubowski MA; Owen DA; Bronner MP
Am J Surg Pathol; 2011 Sep; 35(9):1327-30. PubMed ID: 21836482
[TBL] [Abstract][Full Text] [Related]
35. Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial.
Roh CK; Choi YY; Choi S; Seo WJ; Cho M; Jang E; Son T; Kim HI; Kim H; Hyung WJ; Huh YM; Noh SH; Cheong JH
Yonsei Med J; 2019 Feb; 60(2):132-139. PubMed ID: 30666834
[TBL] [Abstract][Full Text] [Related]
36. Molecular profiling and comprehensive genome-wide analysis of somatic copy number alterations in gastric intramucosal neoplasias based on microsatellite status.
Sugai T; Eizuka M; Arakawa N; Osakabe M; Habano W; Fujita Y; Yamamoto E; Yamano H; Endoh M; Matsumoto T; Suzuki H
Gastric Cancer; 2018 Sep; 21(5):765-775. PubMed ID: 29468422
[TBL] [Abstract][Full Text] [Related]
37. The Role of Microsatellite Instability in Positive Margin Gastric Cancer Patients.
Polom K; Marrelli D; Smyth EC; Voglino C; Roviello G; Pascale V; Varas J; Vindigni C; Roviello F
Surg Innov; 2018 Apr; 25(2):99-104. PubMed ID: 29303062
[TBL] [Abstract][Full Text] [Related]
38. Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes' A to Dukes' B.
Asaka S; Arai Y; Nishimura Y; Yamaguchi K; Ishikubo T; Yatsuoka T; Tanaka Y; Akagi K
Carcinogenesis; 2009 Mar; 30(3):494-9. PubMed ID: 19147861
[TBL] [Abstract][Full Text] [Related]
39. Distinct Histopathologic and Molecular Alterations in Inflammatory Bowel Disease-Associated Intestinal Adenocarcinoma: c-MYC Amplification is Common and Associated with Mucinous/Signet Ring Cell Differentiation.
Hartman DJ; Binion DG; Regueiro MD; Miller C; Herbst C; Pai RK
Inflamm Bowel Dis; 2018 Jul; 24(8):1780-1790. PubMed ID: 29788391
[TBL] [Abstract][Full Text] [Related]
40. Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas.
Reis H; van der Vos KE; Niedworok C; Herold T; Módos O; Szendrői A; Hager T; Ingenwerth M; Vis DJ; Behrendt MA; de Jong J; van der Heijden MS; Peyronnet B; Mathieu R; Wiesweg M; Ablat J; Okon K; Tolkach Y; Keresztes D; Nagy N; Bremmer F; Gaisa NT; Chlosta P; Kriegsmann J; Kovalszky I; Timar J; Kristiansen G; Radzun HJ; Knüchel R; Schuler M; Black PC; Rübben H; Hadaschik BA; Schmid KW; van Rhijn BWG; Nyirády P; Szarvas T
Int J Cancer; 2018 Oct; 143(7):1764-1773. PubMed ID: 29672836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
